How is Calf Muscle Endurance Related to Ankle Injuries in TeamGym Athletes?

February 27, 2024 updated by: Susanne Beischer

The specific aims of this study are to:

  • describe how many heel raises and side hops TG athletes of various ages can perform and how far they can jump, one leg at a time.
  • examine how calf muscle endurance and hop performance are related to the risk of new injuries in the foot, ankle, and lower leg in TG athletes.

The investigators hypothesise that atletes with superior performance in the tests for muscular endurance and hop performance will report fewer injuries during the follow up period.

Study Overview

Detailed Description

TeamGym (TG) is the most common gymnastics discipline in Sweden. There is a relatively high injury incidence of 2,2-3,4 injuries per 1000 hours of gymnastic activity. Muscular fatigue has been proposed as a risk factor for sustaining an injury in gymnastics, but this has yet not been examined.

In TG, the lower extremity is more susceptible to injuries than the spine and upper extremity, with injury rates ranging between 60 - 77% for the lower extremity. More specifically, the foot, ankle, and the lower leg account for 40 - 56% of all reported injuries, consisting mostly of ankle injuries.

In clinical and research settings, heel raises and side hops are commonly used to assess muscular endurance in the lower leg. Furthermore, it is common to also include a hop performance test to assess the physical capacity of an athlete following an injury to the foot, ankle, or lower leg. However, there are normative values published of the aforementioned tests, in TG athletes

The overall purpose of this project is to facilitate and improve the caretaking of TG athletes who have sustained various types of injuries in the foot, ankle and lower leg.

Specific aims are to:

  • describe how many heel raises and side hops TG athletes of various ages can perform and how far they can jump, one leg at a time.
  • examine how calf muscle endurance and hop performance are related to the risk of new injuries in the foot, ankle, and lower leg in TG athletes.

The investigatorshypothesise that atletes with superior performance in the tests for muscular endurance and hop performance will report fewer injuries during the follow up period.

About 200 athletes who regulary participate in TeamGym training (at least once per week) and understand written and spoken Swedish will be included in this study.

Athletes with a recent injury to the foot, ankle, or lower leg or the presence of with other injuries to the lower limb or spine that may be accentuated or affect test results will be excluded.

Data regarding numbers of new injuries (acute and overuse injuries) in the foot, ankle and/or lower leg within six months after baseline testing aswell as severity score of the overuse injuries will be measured bi-weekly with the Oslo Sports Trauma Research Center (OSTRC) questionnaire.

Study Type

Observational

Enrollment (Actual)

107

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Gothenburg, Sweden
        • Göteborg University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

TeamGym athletes (members of the Swedish Gymnastics Federation) in Gothenburg, Sweden.

Description

Inclusion Criteria:

  • Regular participation in TeamGym training (at least once per week)
  • Understanding written and spoken Swedish

Exclusion Criteria:

  • Recent (defined as: in the last 4 weeks before baseline testing) injury to the foot, ankle, or lower leg = exclusion from hop tests.
  • Presence of other injuries to the lower limb or spine that may be accentuated or affect test results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
New injury
Time Frame: Within six months after baseline testing.
Number of new acute/overuse injuries in the foot, ankle or lower leg.
Within six months after baseline testing.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of overuse injury
Time Frame: Bi-weekly follow-ups over a 6 month period.
Answers from 4 questions regarding severity are scored from 0 to 25, and summed to calculate a severity score between 0 (= no problems) and 100 (= maximum level of problems).
Bi-weekly follow-ups over a 6 month period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2022

Primary Completion (Actual)

September 16, 2023

Study Completion (Actual)

October 12, 2023

Study Registration Dates

First Submitted

April 5, 2022

First Submitted That Met QC Criteria

April 5, 2022

First Posted (Actual)

April 12, 2022

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

One of the purposes of the project is describing normative data regarding muscular endurance and hop performance in TeamGym athletes and the results will therefore be published. Thus, there will be no need to make IPD available for other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Injuries

3
Subscribe